Real-time monitoring of drug laboratory test interactions: a proof of concept.

Autor: van Balveren JA; Laboratory for Clinical Chemistry and Haematology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Verboeket-van de Venne WPHG; Department of Clinical Chemistry and Hematology, Zuyderland Medical Centre, Heerlen, The Netherlands., Doggen CJM; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Erdem-Eraslan L; Department of Clinical Chemistry, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., de Graaf AJ; Department of Clinical Chemistry and Laboratory Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., Krabbe JG; Department of Clinical Chemistry and Laboratory Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., Musson REA; Laboratory for Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands., Oosterhuis WP; Department of Clinical Chemistry and Hematology, Zuyderland Medical Centre, Heerlen, The Netherlands., de Rijke YB; Department of Clinical Chemistry, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van der Sijs H; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Tintu AN; Department of Clinical Chemistry, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Verheul RJ; Department of Clinical Chemistry and Laboratory Medicine, Haaglanden Medical Centre, The Hague, The Netherlands., Hoedemakers RMJ; Laboratory for Clinical Chemistry and Haematology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Kusters R; Laboratory for Clinical Chemistry and Haematology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Jazyk: angličtina
Zdroj: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2021 Nov 09; Vol. 60 (2), pp. 235-242. Date of Electronic Publication: 2021 Nov 09 (Print Publication: 2022).
DOI: 10.1515/cclm-2021-0790
Abstrakt: Objectives: For the correct interpretation of test results, it is important to be aware of drug-laboratory test interactions (DLTIs). If DLTIs are not taken into account by clinicians, erroneous interpretation of test results may lead to a delayed or incorrect diagnosis, unnecessary diagnostic testing or therapy with possible harm for patients. A DLTI alert accompanying a laboratory test result could be a solution. The aim of this study was to test a multicentre proof of concept of an electronic clinical decision support system (CDSS) for real-time monitoring of DLTIs.
Methods: CDSS was implemented in three Dutch hospitals. So-called 'clinical rules' were programmed to alert medical specialists for possible DLTIs based on laboratory test results outside the reference range in combination with prescribed drugs. A selection of interactions from the DLTI database of the Dutch society of clinical chemistry and laboratory medicine were integrated in 43 clinical rules, including 24 tests and 25 drugs. During the period of one month all generated DTLI alerts were registered in the laboratory information system.
Results: Approximately 65 DLTI alerts per day were detected in each hospital. Most DLTI alerts were generated in patients from the internal medicine and intensive care departments. The most frequently reported DLTI alerts were potassium-proton pump inhibitors (16%), potassium-beta blockers (11%) and creatine kinase-statins (11%).
Conclusions: This study shows that it is possible to alert for potential DLTIs in real-time with a CDSS. The CDSS was successfully implemented in three hospitals. Further research must reveal its usefulness in clinical practice.
(© 2021 Walter de Gruyter GmbH, Berlin/Boston.)
Databáze: MEDLINE